Afficher la couverture 'Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials | Lioger, François' en grand format
/5

0 avis

Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials

Archive ouverte

Lioger, François | Maillot, François | Ternant, David | Passot, Christophe | Paintaud, Gilles | Bejan-Angoulvant, Theodora | Lioger, Bertrand

Edité par CCSD ; Elsevier -

International audience. To compare the efficacy and safety of intravenous immunoglobulins (IVIG) and anti-D immunoglobulin (anti-D) in pediatric immune thrombocytopenia (ITP).

Consulter en ligne

Suggestions

Du même auteur

Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients

Archive ouverte | Lioger, Bertrand | CCSD

International audience. Rituximab is a monoclonal antibody directed against CD20, which is approved in rheumatoid arthritis (RA). This study aimed at assessing the influence of CD19+ cell counts as target-antigen am...

The underlying inflammatory chronic disease influences infliximab pharmacokinetics

Archive ouverte | Passot, Christophe | CCSD

International audience. Infliximab is an anti-tumor necrosis factor monoclonal antibody approved in chronic inflammatory diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis ...

Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases

Archive ouverte | Paintaud, Gilles | CCSD

This is the accepted version of the following article: "Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Diseases", which has been published in final form at https://insights.ovid.com/crossref?an=000...

Chargement des enrichissements...